DK144033C - Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf - Google Patents

Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf

Info

Publication number
DK144033C
DK144033C DK103876A DK103876A DK144033C DK 144033 C DK144033 C DK 144033C DK 103876 A DK103876 A DK 103876A DK 103876 A DK103876 A DK 103876A DK 144033 C DK144033 C DK 144033C
Authority
DK
Denmark
Prior art keywords
dihydroxy
analogue
phenyl
methyl
preparation
Prior art date
Application number
DK103876A
Other languages
English (en)
Other versions
DK144033B (da
DK103876A (da
Inventor
F Braun
K Stach
M Thiel
G Sponer
K Dietmann
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of DK103876A publication Critical patent/DK103876A/da
Publication of DK144033B publication Critical patent/DK144033B/da
Application granted granted Critical
Publication of DK144033C publication Critical patent/DK144033C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08Tripeptides
    • C07K5/0802Tripeptides with the first amino acid being neutral
    • C07K5/0804Tripeptides with the first amino acid being neutral and aliphatic
    • C07K5/0806Tripeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atoms, i.e. Gly, Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06017Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06008Dipeptides with the first amino acid being neutral
    • C07K5/06078Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/80Antihypertensive peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK103876A 1975-03-12 1976-03-10 Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf DK144033C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2510634 1975-03-12
DE19752510634 DE2510634A1 (de) 1975-03-12 1975-03-12 L-3-(3,4-dihydroxy-phenyl)-2- methyl-alanin-peptide und verfahren zu deren herstellung

Publications (3)

Publication Number Publication Date
DK103876A DK103876A (da) 1976-09-13
DK144033B DK144033B (da) 1981-11-23
DK144033C true DK144033C (da) 1982-04-26

Family

ID=5941062

Family Applications (1)

Application Number Title Priority Date Filing Date
DK103876A DK144033C (da) 1975-03-12 1976-03-10 Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf

Country Status (23)

Country Link
US (1) US4087520A (da)
JP (1) JPS51118739A (da)
AR (1) AR207182A1 (da)
AT (1) AT349662B (da)
BE (1) BE839362A (da)
CA (1) CA1051874A (da)
CH (1) CH618961A5 (da)
CS (1) CS193537B2 (da)
DD (1) DD125548A5 (da)
DE (1) DE2510634A1 (da)
DK (1) DK144033C (da)
ES (1) ES445927A1 (da)
FR (1) FR2303535A1 (da)
GB (1) GB1491413A (da)
HU (1) HU171083B (da)
IE (1) IE42785B1 (da)
IT (1) IT1056948B (da)
LU (1) LU74520A1 (da)
NL (1) NL7602391A (da)
PL (1) PL101292B1 (da)
SE (1) SE408412B (da)
SU (1) SU656505A3 (da)
ZA (1) ZA761462B (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH14064A (en) * 1977-05-06 1981-01-26 Pfizer Phenylgycine derivatives,pharmaceutical compositions and method of use
JPS6026099B2 (ja) * 1977-09-21 1985-06-21 財団法人微生物化学研究会 ペプチド、その酸附加塩およびその製造法
PH14681A (en) * 1977-11-30 1981-11-10 Pfizer Phenylglycinamides useful in the treatment of ischaemic heart disease
US4740501A (en) * 1978-07-31 1988-04-26 Debarbieri Augusto Interference of b-type retrovirus replication with a tripeptide compound
US4540683A (en) * 1978-07-31 1985-09-10 Proter S.P.A. In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
IT1134503B (it) 1980-11-28 1986-08-13 Proter Spa Composti della diclorodietilaminofenilalanina ad azione antitumorale
US4743590A (en) * 1978-07-31 1988-05-10 Debarbieri Augusto In vitro and in vivo treatment of cancer cells and treatment of viruses with a tripeptide compound
JPS5767516A (en) * 1980-09-24 1982-04-24 Microbial Chem Res Found Novel analgesic agent
US4666887A (en) * 1980-11-28 1987-05-19 Proter S.P.A. Intravenous or intraperitoneal administration of a tripeptide compound for treating cancer
US4454065A (en) * 1982-05-18 1984-06-12 Smithkline Beckman Corporation Oligopeptide prodrugs

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3803120A (en) * 1971-09-28 1974-04-09 Hoffmann La Roche Di-and tripeptides of 3-(3,4-dihydroxyphenyl)-alanine
US3891696A (en) * 1973-11-02 1975-06-24 Interx Research Corp Novel, transient pro-drug forms of l-dopa

Also Published As

Publication number Publication date
IE42785B1 (en) 1980-10-22
IE42785L (en) 1976-09-12
LU74520A1 (da) 1976-09-01
IT1056948B (it) 1982-02-20
CS193537B2 (en) 1979-10-31
SE408412B (sv) 1979-06-11
SU656505A3 (ru) 1979-04-05
NL7602391A (nl) 1976-09-14
AU1189676A (en) 1977-09-15
DK144033B (da) 1981-11-23
CH618961A5 (da) 1980-08-29
DK103876A (da) 1976-09-13
GB1491413A (en) 1977-11-09
SE7602135L (sv) 1976-09-13
DE2510634A1 (de) 1976-09-23
AT349662B (de) 1979-04-25
JPS51118739A (en) 1976-10-18
DD125548A5 (da) 1977-05-04
CA1051874A (en) 1979-04-03
ZA761462B (en) 1977-04-27
US4087520A (en) 1978-05-02
BE839362A (fr) 1976-09-09
HU171083B (hu) 1977-11-28
PL101292B1 (pl) 1978-12-30
ES445927A1 (es) 1977-05-01
FR2303535A1 (fr) 1976-10-08
ATA180676A (de) 1978-09-15
FR2303535B1 (da) 1978-11-17
AR207182A1 (es) 1976-09-15

Similar Documents

Publication Publication Date Title
DK145339C (da) Analogifremgangsmaade til fremstilling af 4-amino-5-hexensyre eller farmaceutisk acceptable salte deraf
DK154654C (da) Analogifremgangsmaade til fremstilling af immunmodulerende 2-oe2-acylamino-2-desoxy-(d)-glucosyl-3-oaa-alkancarboxylsyrepeptid-derivater eller farmaceutisk acceptable salte deraf
DK143227C (da) Analogifremgangsmaade til fremstilling af substituerede 2,2'-methylendiphenoler eller farmakologisk acceptable salte deraf
DK153397C (da) Analogifremgangsmaade til fremstilling af 1,3,4-trisubstituerede 4-arylpiperidiner eller farmaceutisk acceptable syreadditionssalte deraf
DK152114C (da) Analogifremgangsmaade til fremstilling af propenylaminer eller farmaceutisk acceptable salte deraf
DK146538C (da) Analogifremgangsmaade til fremstilling af 7alfa-methoxycephalosporinderivater eller farmaceutisk acceptable salte deraf
DK157246C (da) Analogifremgangsmaade til fremstilling af n-acylamino-alfa-phenylacetamidocephalosporiner eller farmaceutisk acceptable salte heraf.
DK146160C (da) Analogifremgangsmaade til fremstilling af n-(5-tetrazolyl)-4-oxo-4h-pyrimido(2,1-b)benzothiazol-3-carboxamider eller farmaceutisk acceptable salte deraf med baser
DK142948C (da) Analogifremgangsmaade til fremstilling af biphenylyl-acetylaminopyridiner eller fysiologisk acceptable salte heraf
DK158658C (da) Analogifremgangsmaade til fremstilling af 9-aminoalkylfluorener eller farmaceutisk acceptable salte deraf
DK144033C (da) Analogifremgangsmaade til fremstilling af l-3-(3,4-dihydroxy-phenyl)-2-methyl-alanin-peptider eller farmakologisk acceptable salte deraf
DK151805C (da) Analogifremgangsmaade til fremstilling af 20,21-di-nor-eburnameninderivater eller farmaceutisk acceptable additionssalte deraf
DK145263C (da) Analogifremgangsmaade til fremstilling af imidazothiaziner eller farmaceutisk acceptable salte deraf
DK143105C (da) Analogifremgangsmaade til fremstilling af aminobenzocycloheptenderivater eller farmaceutisk acceptable additionssalte deraf
DK159654C (da) Analogifremgangsmaade til fremstilling af aminosyrederivater eller fysiologisk acceptable salte deraf
DK151028C (da) Analogifremgangsmaade til fremstilling af 1,3-tiazolo(4,3-a)isokinoliner eller salte deraf
DK150521C (da) Analogifremgangsmaade til fremstilling af n2-arylsulfonyl-l-argininamider eller farmaceutisk acceptable salte deraf
DK157021C (da) Analogifremgangsmaade til fremstilling af 2,3-polymethylen-4-oxo-4h-pyrido- eller -azepinooe1,2-aaapyrimidiner eller farmaceutisk acceptable syreadditionssalte eller kvaternaere salte deraf
DK143197C (da) Analogifremgangsmaade til fremstilling af 5,7-dihydroxy-tetrahydroisoquinoliner eller farmaceutisk acceptable syreadditionssalte deraf
DK151254C (da) Analogifremgangsmaade til fremstilling af 2-hydroxymethyl-pyrazin-derivater eller farmaceutisk acceptable salte deraf
DK147577C (da) Analogifremgangsmaade til fremstilling af 2-phenyl-bicyclooctan- eller -octenaminer eller farmaceutisk acceptable syreadditionssalte deraf
DK156271C (da) Analogifremgangsmaade til fremstilling af 1,2-5,6-dianhydro-3,4-di-o-acylgalactitolderivater
DK144656C (da) Analogifremgangsmaade til fremstilling af alkylphenylbenzopyranopyridiner eller pharmaceutiske acceptable salte deraf
DK147105C (da) Analogifremgangsmaade til fremstilling af 4,4'-dihydroxy-3,3'-diphenylarylmethandicarboxylsyrer eller farmaceutisk acceptable salte heraf
DK143750C (da) Analogifremgangsmaade til fremstilling af 1,2,3,4-tetrahydroisoquinoliner